Talis Biomedical TLIS Stock
Talis Biomedical Price Chart
Talis Biomedical TLIS Financial and Trading Overview
| Talis Biomedical stock price | 2.84 USD |
| Previous Close | 2.84 USD |
| Open | 1.6 USD |
| Bid | 1.56 USD x 308300 |
| Ask | 1.6 USD x 40000 |
| Day's Range | 1.6 - 1.6 USD |
| 52 Week Range | 1.04 - 2.84 USD |
| Volume | 1.68K USD |
| Avg. Volume | 1.18K USD |
| Market Cap | 5.18M USD |
| Beta (5Y Monthly) | 1.321 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TLIS Valuation Measures
| Enterprise Value | -35887192 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.121783875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.688255 |
| Price/Book (mrq) | 0.10643081 |
| Enterprise Value/Revenue | -87.959 |
| Enterprise Value/EBITDA | 0.787 |
Trading Information
Talis Biomedical Stock Price History
| Beta (5Y Monthly) | 1.321 |
| 52-Week Change | 76.39% |
| S&P500 52-Week Change | 15.12% |
| 52 Week High | 2.84 USD |
| 52 Week Low | 1.04 USD |
| 50-Day Moving Average | 2.37 USD |
| 200-Day Moving Average | 1.72 USD |
TLIS Share Statistics
| Avg. Volume (3 month) | 1.18K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 1.82M |
| Float | 1.31M |
| Short Ratio | 0.59 |
| % Held by Insiders | 8.30% |
| % Held by Institutions | 28.33% |
| Shares Short | 17.96K |
| Short % of Float | 1.54% |
| Short % of Shares Outstanding | 0.99% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -11360.29% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.59% |
| Return on Equity (ttm) | -70.48% |
Income Statement
| Revenue (ttm) | 408K USD |
| Revenue Per Share (ttm) | 0.22 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -20089000 USD |
| EBITDA | -45576000 USD |
| Net Income Avi to Common (ttm) | -51026000 USD |
| Diluted EPS (ttm) | -28.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 59.87M USD |
| Total Cash Per Share (mrq) | 32.84 USD |
| Total Debt (mrq) | 18.8M USD |
| Total Debt/Equity (mrq) | 38.66 USD |
| Current Ratio (mrq) | 7.76 |
| Book Value Per Share (mrq) | 26.684 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40258000 USD |
| Levered Free Cash Flow (ttm) | -25909750 USD |
Profile of Talis Biomedical
| Country | United States |
| State | IL |
| City | Chicago |
| Address | 1375 West Fulton Market |
| ZIP | 60607 |
| Phone | 650-433-3000 |
| Website | https://talisbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 99 |
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
Q&A For Talis Biomedical Stock
What is a current TLIS stock price?
Talis Biomedical TLIS stock price today per share is 2.84 USD.
How to purchase Talis Biomedical stock?
You can buy TLIS shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Talis Biomedical?
The stock symbol or ticker of Talis Biomedical is TLIS.
Which industry does the Talis Biomedical company belong to?
The Talis Biomedical industry is Medical Devices.
How many shares does Talis Biomedical have in circulation?
The max supply of Talis Biomedical shares is 1.82M.
What is Talis Biomedical Price to Earnings Ratio (PE Ratio)?
Talis Biomedical PE Ratio is 0.00000000 now.
What was Talis Biomedical earnings per share over the trailing 12 months (TTM)?
Talis Biomedical EPS is 0 USD over the trailing 12 months.
Which sector does the Talis Biomedical company belong to?
The Talis Biomedical sector is Healthcare.
Talis Biomedical TLIS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}